Medtronic, Johnson & Johnson may be helped by latest China tariff cuts — Panjiva


Medtronic, Johnson & Johnson may be helped by latest China tariff cuts

China 2290 Health Care 164 Tariffs 1528 Trade Deals 821 U.S. 4075

The Chinese government has cut tariffs on imports of 65 products from the U.S. which were worth $5.0 billion in 2019. The largest product lines were medical devices and related equipment worth $2.26 billion with other products including hydraulic machinery, wood and books. The reductions serve the dual purposes of fulfilling phase 1 trade deal commitments as well as managing healthcare costs during the COVID-19 coronavirus outbreak. Leading exporters of medical devices to China in 2017 – before tariffs were introduced – were Medtronic, Johnson & Johnson and Becton Dickinson. U.S. exports...

PANJIVA RESEARCH is a service provided by Panjiva, Inc. ("Panjiva") to relevant global subscribers, and are deemed to be Panjiva "Services" subject to the Panjiva Terms & Conditions of Use. Information contained within or made available via the Services is for informational purposes only and nothing in the Services shall constitute or be construed as an offering of financial instruments, or as investment advice or recommendations by Panjiva, Inc. or its affiliates of an investment strategy or whether to "buy", "sell" or "hold" an investment. The Services may include views and commentary about customers of Panjiva. No aspect of the Services is based on consideration of your individual circumstances, and you should determine on your own whether you agree with the information contained within or made available via the Services. Employees involved in Panjiva Research may hold positions in securities analyzed or discussed in the Services. Panjiva does not make any express or implied warranties, representations, endorsements or conditions with respect to the Services and the information contained within or made available via the Services, including without limitation, warranties as to the usefulness, completeness, accuracy, currentness, reliability or sufficiency of any information (including, without limitation, conclusions, statements, opinions, estimates, forecasts or projections of any kind) and expressly disclaims any implied warranties. Neither this disclaimer nor any of its contents may be forwarded or redistributed without the prior written consent of Panjiva. © 2020 S&P Global. All Rights Reserved.